The goal of the NCI is to eliminate the suffering and death due to cancer. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.
The SBIR & STTR Programs are one of the largest sources of early-stage technology
financing in the United States. We welcome entrepreneurs and small business leaders
to this website to explore grant and contract funding opportunities and a new spirit
of collaboration with the NCI.
[Learn More]
Click here to view online resources that help small businesses prepare their grant applications and contract proposals. Resources include annotated SBIR grant applications, videos with tips for applying for NCI SBIR & STTR funding, and guidance on the electronic submission process.
While there are no actual examples of SBIR contract applications available, the slides from these recent SBIR & STTR Program information sessions provide valuable insight into the application process. In addition, visit the How to Apply section on the SBIR Web site for examples of SBIR grant applications. Please note that all contract applications must be submitted via paper application.
The NCI SBIR will host its second Investor Forum designed to connect the strongest and most promising NCI SBIR funded companies with life science investors and strategic partners. This is a rare occasion for attendees to get a first look at some of the best early-stage oncology companies currently funded by the NCI, and to establish new collaborations. Learn more.
NCI SBIR & STTR Grant Funding Available for:
- Image-Guided Cancer Interventions
- Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens
- Technologies and Software to Support Integrative Cancer Biology Research
- Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs
Application receipt dates: August 5; December 5, 2010
SBIR & STTR Omnibus Solicitation
U.S. small businesses with the research capabilities and technological expertise established in the Omnibus solicitation are encouraged to submit investigator-initiated grant applications. View a list of high-priority research areas of the National Cancer Institute. Learn more about the 2010 Omnibus Solicitation.
Application receipt dates: August 5; December 5, 2010
For a complete list of funding opportunities, click here.
NCI is seeking highly motivated applicants with strong industry or venture capital
experience for positions within the NCI SBIR Program.
Click here to learn more.
